Founded in 2017, Cutaneous NeuroDiagnostics (CND) is the only commercial diagnostic laboratory specializing in the detection of neurodegenerative disease, particularly synucleinopathy, small fiber neuropathy and amyloidosis, through the examination of skin tissue. CND offers medical practitioners and their patients objective evidence to aid in the diagnosis of the potential underlying neurological disease

Who Should be Tested for Synucleinopathy?
Patients with:
• A movement disorder that may be related to α-synuclein deposition (PD, MSA, PAF, LBD)
• Autonomic dysfunction in whom MSA or PAF is suspected
• REM sleep behavior disorder in whom an α-synucleinopathy is suspected

Who Should be Tested for Small Fiber Neuropathy?

Patients with:
• Neuropathic pain and a normal electromyography (EMG) and nerve conduction study (NCV)
• Unexplained widespread pain consistent with SFN
• Autonomic dysfunction suggestive of SFN